1st Quarter - Report

NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES

Firm
Client
Income
—
Expenses
$470,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R.3590, Patient Protection and Affordable Care Act H.R.4872: Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemptionof pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exmpetion from Medicare Part B reguations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S. 1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221 Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and dislosure requirements in the FEHBP. S. 3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
DIANE L DARVEY —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
KEVIN N NICHOLSON —
MARC SCHLOSS —

Contacted: Drug Enforcement Administration (DEA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA); Consumer Product Safety Commission (CPSC); Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 511 (111th), H.R. 616 (111th), S. 956 (111th), H.R. 3663 (111th), H.R. 1970 (111th), H.R. 3962 (111th), S. 1490 (111th), S. 256 (111th), H.R. 3108 (111th), H.R. 4872 (111th), S. 3000 (111th), H.R. 4489 (111th), H.R. 3590 (111th), H.R. 2221 (111th)

Law Enforcement/Crime/Criminal Justice LAW

H.R. 1173, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R. 1166, the E-fencing Enforcement Act of 2008, as related to the prosecution of organized theft. H.R. 4011, Organized Retail Crime Prevention and Enforcement Act of 2009, as related to the prosecution of organized theft. S. 470, Combating Organized Retail Crime Act of 2009, as related to the prosecution of organized theft.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
KEVIN N NICHOLSON —
MARC SCHLOSS —

Contacted: Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); SENATE; Health & Human Services, Dept of (HHS); Consumer Product Safety Commission (CPSC); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); White House Office; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1173 (111th), H.R. 4011 (111th), S. 470 (111th), H.R. 1166 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.